$SUPN #Stocks #StockMarket #SupernusPharmaceuticals released Q4 EPS on https://t.co/savSNTKlN1: Eps growth has accelerated in the to 29.38 % at $0.62 per share, compared to EPS growth rates achieved in the same quarter a year ago, while Sales grew by… https://t.co/F8uuSZQtCL